Ken Griffin Bausch & Lomb Corp Transaction History
Citadel Advisors LLC
- $509 Billion
- Q1 2024
A detailed history of Ken Griffin (Citadel Advisors LLC) transactions in Bausch & Lomb Corp stock. As of the latest transaction made, Citadel Advisors LLC holds 5,100 shares of BLCO stock, worth $75,939. This represents 0.0% of its overall portfolio holdings.
Number of Shares
5,100
Previous 44,200
88.46%
Holding current value
$75,939
Previous $754,000
88.33%
% of portfolio
0.0%
Previous 0.0%
Shares
6 transactions
Others Institutions Holding BLCO
# of Institutions
92Shares Held
37.6MCall Options Held
15.4KPut Options Held
127K-
Fil LTD Hamilton, D08.19MShares$122 Million0.15% of portfolio
-
Goldentree Asset Management LP New York, NY4.72MShares$70.2 Million6.58% of portfolio
-
Maple Rock Capital Partners Inc. Toronto, A63.75MShares$55.8 Million3.59% of portfolio
-
Icahn Carl C Sunny Isles Beach, FL3.5MShares$52.1 Million0.54% of portfolio
-
River Road Asset Management, LLC1.89MShares$28.1 Million0.45% of portfolio
About Bausch & Lomb Corp
- Ticker BLCO
- Exchange NYSE
- Sector Healthcare
- Industry Medical Instruments & Supplies
- Shares Outstandng 350,000,000
- Market Cap $5.21B
- Description
- Bausch + Lomb Corporation operates as an eye health company worldwide. It operates through three segments: Vision Care/Consumer Health Care, Ophthalmic Pharmaceuticals, and Surgical. The Vision Care/Consumer Health Care segment provides contact lens that covers the spectrum of wearing modalities, including daily disposable and frequently replace...